Read the full story from Wisconsin State Journal here. A Promega Corp. product received approval from the U.S. Food and Drug Administration to be used in the Centers for Disease Control and Prevention’s test for the new coronavirus. The Fitchburg-based company announced Wednesday that one of its master mixes is approved under an FDA Emergency […]
Read the full story from WARF here. An international collaboration of virologists at the University of Wisconsin–Madison and the vaccine companies FluGen and Bharat Biotech has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR. Based on […]
Read the full press release from Amgen here. Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19. The mutually exclusive collaboration brings together Adaptive’s proprietary immune medicine […]
Read the full story from BizTimes here. Milwaukee-based Versiti, Inc. will soon begin collecting plasma from recovered COVID-19 patients to potentially treat those with the virus. As researchers race to develop vaccines and treatments for COVID-19, blood centers across the country are beginning to collect plasma for the investigational therapy, which is expected to be […]
Read the full story from BizTimes here. Wisconsin Gov. Tony Evers announced on Monday a new public-private partnership that is expected to double the state’s current COVID-19 testing capacity. Under the partnership, labs operated by Madison-based Exact Sciences Corp., Marshfield Clinic Health System, Madison-based Promega Corp. and UW Health will join an existing network of […]
Read the full story from BizTimes here. A team of Wisconsin brain experts and University of Wisconsin-Milwaukee app developers have created a new tool that is designed to improve care and reduce hospital stays for brain cancer patients. NIMBLE – Network for the Integrated Management of Brain Metastasis: Linking Experts – is a mobile app […]
Read the full story from Wisconsin State Journal here. fter Tobias Zutz raised $900,000 for Gregor Diagnostics, his Madison startup developing a new test for prostate cancer, he didn’t want to spend a big chunk of the money on lab equipment right away. He moved into Forward Biolabs, a biotech incubator at University Research Park […]
Read the full press release here. With promising results on its first rheumatological protein therapies, Dianomi is strategically expanding upon its core technology to deliver next-generation nucleic acid therapies MADISON, Wis., Feb. 11, 2020 /PRNewswire/ — Dianomi Therapeutics Inc. today announced that it has licensed a second suite of intellectual property (IP) from the Wisconsin Alumni Research Foundation […]
Read the full press release from UW Health here. Doctors at UW Health became the first in the U.S. to treat a patient using a new medical imaging device that allows physicians to see inside blood vessels and organs during surgery. The new system, the ARTIS icono biplane from Siemens Healthineers, was installed at University […]
Read the full story from BizJournals here. Cancer diagnostics company Exact Sciences Corp. has more than doubled the capital investment and job creation numbers it proposed under an agreement with the Wisconsin Economic Development Corp., according to documents obtained by the Milwaukee Business Journal per a public records request. In 2015, Madison-based Exact Sciences was approved […]